← Open Payments lookup

NPI 1548612807: Open Payments

NPI 1548612807. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$821 in 35 payments from 10 companies in 2025. Trend: 2023 $261 · 2024 $421 · 2025 $821

Food & beverage: $756Education: $45Speaker / faculty: $20
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$321
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$157
Novo Nordisk Inc3$67
Axsome Therapeutics, Inc.3$62
Lilly USA, LLC2$59
Exact Sciences Corporation3$57
GlaxoSmithKline, LLC.2$38
PFIZER INC.1$24
Becton, Dickinson and Company1$20
BeOne Medicines USA, Inc.1$18

Products named: BREZTRI, CAPLYTA, FARXIGA, Ozempic, The Cologuard Plus Collection Kit, TRELEGY ELLIPTA, Auvelity, Symbravo.